Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia
Key facts
- Who runs it
- Yale University
- Where
- Malaysia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 2 people enrolled
- Started
- 26 Apr 2022
- Ended
- 31 May 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Enhanced usual care (EUC)
- Peer-based counseling
- Record updated
- 29 June 2026
- Why it stopped
- lack of eligible participants
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- potential participants must meet the inclusion criteria for ART and MMT and begin receiving these treatments
Who cannot take part
- ART and MMT exclusion criteria include: liver enzymes greater than 5 times the upper limit of normal (ULN); liver failure (Childs Pugh Turcot Grade B or C)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This pragmatic, multisite, implementation and effectiveness research evaluates a strategy to improve HIV treatment outcomes (increased rates of patients on ART with virological suppression, improved treatment retention and ART adherence) for people living with HIV (PLWH) with opioid use disorder (OUD). Engaging 4 large regional HIV/AIDS treatment centers in Malaysia, the study will evaluate barriers and facilitators for implementation of improved care model and will evaluate the comparative effectiveness of the model in a clinical trial. The research will provide critically important evidence for implementation of effective Seek-Test-Treat, and Retain models for PLWH and OUD throughout Malaysia and inform healthcare policy in other low to middle income countries and regions with limited healthcare resources.
The 2 groups in the trial
- Enhanced usual care (EUC)Existing treatment, for comparison
The EUC consists of provision of ART and medical care for HIV and other medical HIV co-morbidities provided at the HIV/AIDS treatment center with an expedited and facilitated referral to a methadone maintenance treatment (MMT).
- Fully Implemented Seek-Test-Treat-Retain (FI-STTR) modelTreatment being tested
The FI-STTR care model will include the usual care supplemented by continuing education and coaching of medical staff at HIV/AIDS and MMT clinics and by provision of additional peer-based counseling intervention
Treatment: Enhanced usual care (EUC) and Peer-based counseling
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Implementation of Seek, Test, Treat & Retain Strategies Among People Who Inject Drugs in Malaysia
- Record updated
- 29 June 2026